~~<i id='FD3A4CC07B'><strike id='FD3A4CC07B'><tt id='FD3A4CC07B'><pre id='FD3A4CC07B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

focus

author：hotspot 2025-09-27 19:27:56 - browse：773

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Aspartame and sugar

leisure time

hotspot

explore

leisure time

AdobeSANDIEGO—Afterstartingofftheyearwithlowerrevenueprojectionsthanmarketanalystshadhopedfor,SanDie

WSS

Aspartame and sugar

After Optum profits sink, UnitedHealth makes changes

FTX founder Sam Bankman

Biden administration begins canceling student loan debt for 804,000 borrowers

Indictment alleges Trump's ex

Lessons Learned: This is why you network to find that industry job you want

knowledge

focus

leisure time

How to save PrEP access — and even expand it

Lessons Learned: This is why you network to find that industry job you want

Cancer drug shortages should be causing more outrage

Former Georgia lieutenant governor says he received grand jury subpoena

Drug repurposing or repositioning? The language matters

FTX founder Sam Bankman

After affirmative action ruling, medical educators look to 'holistic review'

Be careful with at

Hepatitis C has a cure — but many Americans still lack access to it

After Optum profits sink, UnitedHealth makes changes

hotspot

Mark Cuban is blaming the wrong people for high drug costs

More regulation could be coming for drug ads

After Optum profits sink, UnitedHealth makes changes

Travel bans should be based on evidence, not politics or fear

Judge sides with young activists in first

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

hotspot

explore

leisure time

leisure time